Literature DB >> 15703406

Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits.

Mathias Pessiglione1, Dominique Guehl, Anne-Sophie Rolland, Chantal François, Etienne C Hirsch, Jean Féger, Léon Tremblay.   

Abstract

Different analyses of neuronal activity in primate models of Parkinson's disease (PD) have resulted in two different views on the effects of dopamine depletion. The first is based on the higher firing rate and bursty firing pattern, and assumes that dopamine depletion results in a hyperactivity of basal ganglia (BG) output structures. The second is based on the less-specific responses to passive joint manipulation and the excessive correlations between neuronal discharges, and assumes that dopamine depletion results in a loss of functional segregation in cortico-BG circuits. The aim of the present study was to test out the predictions of these two different views on thalamic neuronal activity. Three male vervet monkeys (Cercopithecus aethiops) were progressively intoxicated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuronal activities were characterized using standard analyses (firing rates and patterns, receptive fields, and cross-correlations) and compared between the normal, asymptomatic (before the stabilization of motor symptoms), and parkinsonian (with persistent akinesia and rigidity) stages of MPTP intoxication. The pallidonigral thalamus (receiving projections from the BG) was characterized in both the asymptomatic and parkinsonian states by (1) an unchanged firing rate and pattern and (2) a proliferation of nonspecific neurons and correlated pairs. In contrast, the cerebellar thalamus (receiving projections from the cerebellum), was characterized by no change (asymptomatic state) or minor changes (symptomatic state). Thus the major dysfunction after dopamine depletion appeared to be the loss of functional segregation within cortico-BG circuits, which could also be at the heart of parkinsonian pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703406      PMCID: PMC6725984          DOI: 10.1523/JNEUROSCI.4056-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Modeling the effects of Deep Brain Stimulation on sensorimotor cortex in normal and MPTP conditions.

Authors:  S Santaniello; J T Gale; E B Montgomery; S V Sarma
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

2.  Parafascicular thalamic nucleus activity in a rat model of Parkinson's disease.

Authors:  Louise C Parr-Brownlie; Stacey L Poloskey; Debra A Bergstrom; Judith R Walters
Journal:  Exp Neurol       Date:  2009-03-05       Impact factor: 5.330

3.  Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons.

Authors:  Benjamin Pasquereau; Robert S Turner
Journal:  Cereb Cortex       Date:  2010-11-02       Impact factor: 5.357

Review 4.  Pathophysiology of parkinsonism.

Authors:  Adriana Galvan; Thomas Wichmann
Journal:  Clin Neurophysiol       Date:  2008-05-07       Impact factor: 3.708

Review 5.  Mechanisms and targets of deep brain stimulation in movement disorders.

Authors:  Matthew D Johnson; Svjetlana Miocinovic; Cameron C McIntyre; Jerrold L Vitek
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

6.  Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.

Authors:  Christian Pifl; Stephen J Kish; Oleh Hornykiewicz
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

Review 7.  Systems approaches to optimizing deep brain stimulation therapies in Parkinson's disease.

Authors:  Sabato Santaniello; John T Gale; Sridevi V Sarma
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-03-20

8.  Primary motor cortex of the parkinsonian monkey: altered encoding of active movement.

Authors:  Benjamin Pasquereau; Mahlon R DeLong; Robert S Turner
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

9.  Somatotopic organization in the internal segment of the globus pallidus in Parkinson's disease.

Authors:  Kenneth B Baker; John Y K Lee; Gaurav Mavinkurve; Gary S Russo; Benjamin Walter; Mahlon R DeLong; Roy A E Bakay; Jerrold L Vitek
Journal:  Exp Neurol       Date:  2010-01-06       Impact factor: 5.330

10.  Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene.

Authors:  Heather A Boger; Lawrence D Middaugh; Vandana Zaman; Barry Hoffer; Ann-Charlotte Granholm
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.